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I. INTRODUCTION
At 10:27 a.m. the Warden held a microphone up to Dennis McGuire and asked for
his last words.1 Dennis McGuire mouthed, “I love you” and “I will see you on the
* Rachael Wood is a student at Cleveland-Marshall College of Law in Cleveland, Ohio.
Rachael will receive her J.D. degree in December 2015. Rachael would like to thank her friends
and family for their support while writing this note. She would also like to thank Professor
Kevin O'Neill for his expertise, optimism, and guidance during this process. This note would
not be possible without Professor O'Neill's assistance.
1

Trial Pleading at ¶ 54, In re Dennis R. McGuire v. Mohr, No. 2:14-CV-00093 (S.D. Ohio
filed Jan. 24, 2014), 2014 WL 309071.

95

96

JOURNAL OF LAW AND HEALTH

[Vol. 29:248

other side” to his wife and daughter sitting in the observation room, minutes before he
was to be executed.2 What normally takes eight minutes,3 took two and a half times
as long4—a full 20 minutes, as Mr. McGuire began writhing in pain, pushing and
arching his back while simultaneously pushing against the gurney. 5 He was able to
get his back and neck off the gurney three to four inches, even though he was strapped
down at the waist, feet and hands.6 During the twenty-minute execution, members of
the execution team had horrified looks on their faces with both wide eyes and shocked
expressions.7 At 10:53 a.m., the Warden pronounced Mr. McGuire dead and another
member of the execution team, who had seen the botched execution unfold mouthed
“I'm sorry” to Mr. McGuire’s family in the observation room. 8
Ohio’s statute for carrying out the death sentence 9 lacks a critical piece of
information—where to purchase drugs used in lethal injections. Before the supply ran
out, Ohio used the drug pentobarbital,10 but switched to a two-drug combination of
midazolam and hydromorphone11 for the execution of Mr. McGuire. Previous
2

Id.

3 See Peter Sergo, How Does Lethal Injection Work, SCIENCELINE (Nov. 12, 2007),
http://scienceline.org/2007/11/ask-sergo-deathpenalty (“According to a 2002 study in the
Journal of Forensic Science, the average length of time from the first injection to death is 8.4
minutes”).
4

See Sergo, supra note 3; see also In re Dennis R. McGuire, supra note 1 at ¶¶ 56, 66.

5

See In re Dennis R. McGuire, supra note 2 at ¶ 55-60, 66.

6

Id.

7

Id. at ¶ 62.

8

Id. at ¶ 67.

9 See Ohio Rev. Code Ann. § 2949.22 (West, Westlaw through Files 1 to 140 and
Statewide Issue 1 of the 130th GA (2013-2014))

“(A) Except as provided in division (C) of this section, a death sentence
shall be executed by causing the application to the person, upon whom the
sentence was imposed, of a lethal injection of a drug or combination of
drugs of sufficient dosage to quickly and painlessly cause death. The
application of the drug or combination of drugs shall be continued until the
person is dead. The warden of the correctional institution in which the
sentence is to be executed or another person selected by the director of
rehabilitation and correction shall ensure that the death sentence is
executed.”
10

State by State Lethal Injection, DEATH PENALTY INFORMATION
http://www.deathpenaltyinfo.org/state-lethal-injection (referring to Ohio in chart).

CENTER,

11 See id; see also WOLTERS KLUWER, LIPPINCOT, WILLIAMS & WILKINS, NURSING 2011
DRUG HANDBOOK 755-56, 778-79 (2011) (Hydromorphone can cause respiratory depression in
which the patient should be monitored constantly. See id. at 755. It is advised that resuscitation
equipment should be available. Id. Overdose of hydromorphone can cause “constricted pupils,
cold clammy skin . . . respiratory depression . . . cardiac arrest [and] death.” Id. at 756.
Midazolam is used to “induce sleepiness and amnesia and to relieve apprehension before
anesthesia or before or during procedures.” Id. at 778); see also Alan Johnson, Ohio Revises
Death Penalty Protocol, Will Delay Executions, COLUMBUS DISPATCH (Jan. 9, 2015)
http://www.dispatch.com/content/stories/local/2015/01/08/death-penalty-protocol.html
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suppliers from overseas are refusing to sell these drugs to prisons, including prisons
in Ohio.12 As a result, the Ohio Department of Rehabilitation and Corrections
(“ODRC”) has turned to compounding pharmacies 13 for a new source of drugs.14
However, compounding pharmacies are highly problematic . . . because they are nonFDA regulated which means that regulation is left to the states. 15 Essentially,
compounding pharmacies “tend to differ from one state to the next, making it difficult
to ensure that compounded drugs are held to consistently high standards of quality,
safety and effectiveness.”16
Ohio’s statute is similar to the death sentence statute in Oklahoma, 17 as both states
statutes are silent on where to obtain drugs used in lethal injections. Notably, both
states have experienced recent botched executions. 18 In response, Judge Frost from
the Southern District of Ohio ordered a stay of all executions in the state until January
15, 2015.19 The first execution under Ohio’s newly adopted execution protocol 20 is
scheduled for January 21, 2016.21 This note argues that the ODRC should not obtain
lethal injection drugs from unregulated compounding pharmacies. Ohio should only
(Recently, the ODRC amended their drug cocktail again: “Ohio will add thiopental sodium, a
drug used previously, and drop the two-drug regimen of midazolam and hydromorphone, which
caused problems in the last execution a year ago. But until the Ohio Department of
Rehabilitation and Correction can get supplies of pentobarbital, a drug already permitted, or
thiopental sodium, executions will be postponed”) (emphasis added).
12 See Alan Johnson, Judge Orders Temporary Moratorium on Ohio Executions,
COLUMBUS DISPATCH (May 29, 2014) http://www.dispatch.com/content/stories/local/
2014/05/28/temporary-moratorium-on-lethal-injections.html.
13

See Deborah W. Denno, Lethal Injection Chaos Post-Baze, 102 GEO. L.J. 1331, 1332
(2014) (“[C]ompounding pharmacies are non-FDA regulated, small scale pharmacies that make
customized drugs on an as-needed basis in response to individual prescriptions”).
14

Johnson, supra note 12.

15

Denno, supra note 13, at 1331.

16

Id. 1332

17

See 22 OKL. ST. ANN. § 1014 (West 2015).

18

See generally Michael L. Radelet, Examples of Post-Furman Botched Executions, DEATH
PENALTY INFORMATION CENTER, http://www.deathpenaltyinfo.org/some-examples-postfurman-botched-executions?scid=8&did=478 (last updated July 24, 2014).
19 See Order, In Re Ohio Execution Protocol Litigation, No. 2:11-cv-01016 (S.D. Ohio Aug.
18, 2014), ECF No. 492; see also Order, In Re Ohio Execution Protocol Litigation, No. 2:11cv-01016 (S.D. Ohio Dec. 23, 2014), ECF No. 503.
20

See ODRC OHIO EXECUTION PROTOCOL,
http://drc.ohio.gov/web/drc_policies/documents/01-COM-11.pdf (last updated Jan. 9, 2015)
(“If a sufficient quantity of pentobarbital or thiopental sodium is available, then the scheduled
execution shall proceed with intravenous administration of either pentobarbital or thiopental
sodium, as determined by the Warden, in accordance with the terms of this policy. If a
sufficient quantity of pentobarbital or thiopental sodium is not available, or if at any time the
available pentobarbital or thiopental sodium is deemed unusable by the Medical Team, then
the Warden shall consult with the Director and they shall notify the Governor”).
21 See Execution Schedule, OHIO DEP’T OF REHABILITATION AND CORRECTION, http://
www.drc.ohio.gov/Public/executionschedule.htm (last updated Jan. 30, 2015).
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purchase drugs from an FDA-registered outsourcing facility. Part II explores the death
sentence statute in Ohio and the use of compounding pharmacies. Part III compares
Oklahoma’s statute in conjunction with Ohio and illustrates the adverse effects by
utilizing compounding pharmacies. Part IV proposes recommendations to Ohio’s
execution protocol. Part V provides a conclusion.
II. BACKGROUND
Ohio’s implementation of the death sentence statute22 is minimal in prescribing the
precise manner for carrying out the lethal injection protocol. Instead, Ohio’s execution
protocol, designed and written by the Warden himself, designates the Warden to be in
charge, with the assistance of medical personnel, for carrying out all death sentences.23
Currently, the execution statute simply requires that the:
[D]eath sentence shall be executed by causing the application to the person,
upon whom the sentence was imposed, of a lethal injection of a drug or
combination of drugs of sufficient dosage to quickly and painlessly cause
death. The application of the drug or combination of drugs shall be
continued until the person is dead.24
The statute is silent on where to purchase these drugs, which has afforded the
ODRC, specifically the Warden, enormous freedom in purchasing these life-ending
drugs.25 As a result, Ohio has suffered negative consequences from utilizing
compounding pharmacies to purchase these drugs, which were brought to the public
light by the unfortunate botched execution of Dennis McGuire. 26

22

See OHIO REV. CODE ANN. § 2949.22 (West 2015).

See Ohio Execution Protocol, supra note 20 (“The Warden of that facility, or Deputy
Warden in the absence of the Warden, is responsible for carrying out the death sentence on the
date established by the Ohio Supreme Court. At least three Medical Team Members, two of
whom are authorized to administer drugs under Ohio law, shall be used in the conduct of courtordered executions. Functions required to be performed by medically-qualified persons, as
described in this policy, shall be performed by Medical Team Members”).
23

24

Id.

25 See e.g., Alan Johnson, Ohio Can Use Compounding Pharmacies for Execution Drugs,
COLUMBUS DISPATCH (Oct. 5, 2013), http://www.dispatch.com/content/stories/local/
2013/10/04/new-drugs-added-to-Ohio-execution-policy.html; see also OHIO REV. CODE ANN.
§ 2949.22 (West 2015) (“The Warden controls most aspects of the death sentence: “A death
sentence shall be executed within the walls of the state correctional institution designated by
the director of rehabilitation and correction as the location for executions, within an enclosure
to be prepared for that purpose, under the direction of the warden of the institution or, in the
warden's absence, a deputy warden, and on the day designated by the judge passing sentence
or otherwise designated by a court in the course of any appellate or post-conviction
proceedings.”) (emphasis added).
26 See e.g., Gary Strauss, Ohio Killer's Slow Execution Raises Controversy, USA TODAY
(Jan. 16, 2014), http://www.usatoday.com/story/news/nation/2014/01/16/ohio-killer-executedwith-new-lethal-drug-combo/4512651/.
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A. Ohio’s Death Sentence Statute: A Historical Approach
Ohio has employed three different methods of capital punishment: public
hangings, electrocution, and the current method of lethal injection.27 When Ohio was
first recognized as a state in 1803, executions were performed by public hangings,
before Ohio switched to the electric chair. 28 In 1993, inmates on death row could
choose between the electric chair and lethal injection. 29 A few years later in 2001,
Ohio Governor Bob Taft signed a bill that eliminated the electric chair completely,
leaving lethal injection as the only option. 30
Before a death sentence is imposed on a defendant, there are numerous steps
throughout the judicial process that must be satisfied. First and foremost, Ohio courts
that seek the death penalty, or a life sentence, must comply with the Ohio Revised
Code (“ORC”) section 2929.04,31 which specifies a number of aggravating and
mitigating factors to be evaluated by either a trial judge, jury, or three judge panel. 32
To date, Ohio has executed 393 convicted murderers by a combination of the three
methods.33
1. A Glimpse into Ohio’s Death Penalty Process
In Ohio, in order for the prosecutor to seek the death penalty, certain aggravating
factors must be specified on the indictment and proven beyond a reasonable doubt.34
For example, one aggravating factor purports that:

27 See generally Capital Punishment in Ohio, OHIO DEPARTMENT OF REHABILITATION AND
CORRECTION, http://www.drc.ohio.gov/public/capital.htm (last updated Sept. 14, 2014) (“On
November 15, 2001, Governor Bob Taft signed House Bill 362 eliminating the electric chair as
a form of execution.” Id. “The only method of execution in Ohio is lethal injection.” Id. “On
February 26, 2002, Ohio’s electric chair, nicknamed "Old Sparky," was decommissioned and
disconnected from service.” Id. “The original electric chair was donated to the Ohio Historical
Society on December 18, 2002, and a replica electric chair was donated to the Mansfield
Reformatory Preservation Society.” Id.)

Id. (“Capital punishment has been a part of Ohio’s justice system since early in the state’s
history. From 1803, when Ohio became a state, until 1885, executions were carried out by public
hanging in the county where the crime was committed. In 1885, the legislature enacted a law
that required executions to be carried out at the Ohio Penitentiary in Columbus.”).
28

29 Id. (“In 1993, a bill granting prisoners the option to choose between death by electrocution
or lethal injection was passed and signed into law by former Governor George V. Voinovich.
The Death Row inmate would be asked to choose between the two methods seven days before
the scheduled execution. The law stipulated that if the prisoner did not choose, the default
method of execution would be death by electrocution.”).
30 Id. (“On November 15, 2001, Governor Bob Taft signed House Bill 362 eliminating the
electric chair as a form of execution. The only method of execution in Ohio is lethal injection.”).
31

See OHIO REV. CODE ANN. § 2929.04 (West 2015).

32

See OHIO REV. CODE ANN. § 2929.03(C)(1)(2)(a)(iii)(b)(i)(West, 2014)); see also OHIO
REV. CODE ANN. § 2929.03(C)(1)(2)(a)(iii)(b)(ii) (West 2105).
33
34

See Capital Punishment in Ohio, supra note 27.

See generally OHIO REV. CODE ANN. § 2929.04(A) (West 2014) (Some aggravating
factors include but are not limited to: the assassination of the President of the United States, or
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The offense was committed while the offender was committing, attempting
to commit, or fleeing immediately after committing or attempting to
commit kidnapping, rape, aggravated arson, aggravated robbery, or
aggravated burglary, and either the offender was the principal offender in
the commission of the aggravated murder or, if not the principal offender,
committed the aggravated murder with prior calculation and design. 35
In addition to weighing the aggravating factors, the trier of fact must also consider
numerous mitigating factors, which include the “nature and circumstances of the
offense, history, character, and background of the offender.”36 The trier of fact must
also evaluate whether the offender was under duress or provocation, and consider the
lack of an offender’s prior criminal history. 37 Lastly, the trier of fact must decide
whether the aggravating factors outweigh the mitigating factors in issuing a death or
life sentence.
There are currently 393 men and one woman sitting on death row in Ohio. 38 In
order for a criminal defendant to be subject to capital punishment there are three main
requirements: he or she must be at least 18 years old when the offense was committed,
the indictment must charge the defendant with aggravated murder plus an aggravating
circumstance specification,39 and he or she must not be mentally retarded.40 In capital
person in line for succession of the presidency, the offense was committed for hire or purpose
of escaping detection or trial, the victim was a law enforcement officer.) Id.
35

Id.

36

Id.

37

See id.

38
See Death Row Inmates, OHIO DEPARTMENT OF REHABILITATION
http://www.drc.ohio.gov/public/deathrow.htm (last updated Dec. 4, 2014).

AND

CORRECTION,

See supra note 34; see also infra note 36, at 5-6 (“The following are Aggravating
Circumstances in Ohio: 1. Assassination of President, Vice President, Governor or Lieutenant
Governor; 2. Committed for hire; Committed for the purpose of escaping detection,
apprehension, trial or punishment of another crime; 4. While in detention or at large from
breaking detention; 5. Prior to the current offense, the offender was convicted of a purposeful
killing or attempt to kill, or the offense was part of a course of conduct involving the purposeful
killing or attempt to kill two or more persons; 6. The victim was a law enforcement officer,
whom the offender knew or had reasonable cause to know was a law enforcement officer. The
law enforcement officer was either engaged in work duties or the offender’s specific purpose
was to kill a law enforcement officer; 7. The offense was committed, while the offender was
committing, attempting to commit, or fleeing after committing or attempting to commit,
kidnapping, rape, aggravated arson, aggravated robbery, or aggravated burglary and the
offender was the principal offender in the aggravated murder, or if not the principal offender,
the aggravated murder was committed by prior calculation and design; 8. Killing of a potential
witness in a criminal case to prevent their testimony; 9. Killing of a person less than 13 years of
age with prior calculation or design; or 10. The offense was committed while the offender was
committing, attempting to commit, or fleeing immediately after committing, or attempting to
commit terrorism”).
39

See Capital Crimes Annual Report, OHIO ATTORNEY GENERAL’S OFFICE (Apr. 1, 2014),
http://www.ohioattorneygeneral.gov/getattachment/f8e455c3-b5b1-4ab5-bc24-4af0ffe41273/
2013-Capital-Crimes-Annual-Report.aspx (Aggravated murder is defined in ORC § 2903.01
and the aggravating circumstances are defined in ORC § 2929.04(A)(1) – (A)(10)). Id. at 4-6.
Furthermore, “Whenever an indictment charges the defendant with capital murder, the clerk of
40
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punishment cases, trials are split into two phases—“the guilty phase and the
sentencing or mitigation phase.”41 A criminal defendant has a right to a trial by jury
during both phases of the trial.42 However, the defendant has an option to waive his
right to a jury trial such that a three-judge panel will decide whether the defendant is
guilty and impose a sentence. 43 Before a criminal defendant can be sentenced, the
prosecutor must prove beyond a reasonable doubt the defendant committed aggravated
murder, in conjunction with an aggravating circumstance.44 Furthermore, the
aggravating circumstance(s) must outweigh any mitigating circumstances. 45
A criminal defendant also has the option to file a petition for a writ a habeas
corpus.46 A writ of habeas corpus orders the custodian of an individual in custody to
produce the individual before a court either to inquire about the individual’s detention,
to testify, or to appear for prosecution. 47 Typically, an inmate files a petition for a writ
of habeas corpus to contest: the way the sentence is being carried out, if that person is
in custody because of something other than a judgment of conviction, or the person is
alleging they are being illegally detained in immigration custody. 48
Once a criminal defendant exhausts all possible appeals,49 the defendant typically
sits on death row for several years, 50 before he or she is put to death. The Warden is
responsible for carrying out the death sentence and must abide to the procedures
prescribed in the Ohio execution protocol in addition to any statutory requirements.51
A medical team of three people assists the Warden and at least two members must be
authorized to administer drugs under Ohio law. 52 All executions in Ohio take place at
the Southern Ohio Correctional Facility, located in Lucasville, Ohio. 53

the court in which the indictment is filed must provide notification to the Ohio Supreme Court.
Notice must be filed within 15 days of the filing of the indictment and shall contain the following
information: the name of the person; the docket number; the name of the court in which the case
will be heard, and the date the indictment was filed.” Id. at 6.; see also State v. Lott, 97 Ohio
St.3d 303 (2002) (establishing Ohio’s procedure for determining mental retardation).
41

Id. at 6.

42

Id.

43

Id.

44

Id. at 7.

45

Id.

46

See U.S. Const. art I, § 9, cl. 2; see also Petition for a Writ of Habeas Corpus Form, U.S.
COURTS, available at http://www.uscourts.gov/uscourts/FormsAndFees/Forms/AO242.pdf.
47 See Service of Process, Writ of Habeas Corpus, U.S. MARSHALS SERVICE, http://www.
usmarshals.gov/process/habeas.htm (last visited Mar. 15, 2015).
48

See Petition for a Writ of Habeas Corpus Form, supra note 46.

49

See Capital Crimes Annual Report, supra note 40, at 8.

50

Id. at 24 (“The average numbers of years on death row in Ohio is 15.68 years”).

51

See OHIO EXECUTION PROTOCOL, supra note 20.

52

Id. at 3.

53

Id. at 4.
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2. Dennis McGuire: Ohio’s Most Recent Execution
Dennis McGuire experienced horrific complications during his execution in
January 2014.54 Keeping in mind the end result of this execution, it is critical to
understand Mr. McGuire’s case, and how he ended up on death row. Mr. McGuire
was indicted on December 22, 1993, and was sentenced to death on December 23,
1994.55 After numerous unsuccessful appeals, Mr. McGuire was the “[o]nly person in
Ohio to have been put to death using the combination of midazolam and
hydromorphone.”56
In the case of Dennis McGuire, the victim, Joy Stewart, approached Mr. McGuire
because she wanted to purchase marijuana from him.57 The following day, Joy’s body
was found in the woods.58 This homicide was investigated by the Preble County
Prosecutor’s Office, but to no immediate avail. 59 However, Mr. McGuire, while
incarcerated on an unrelated offense, informed law enforcement that he had inside
knowledge pertaining to Joy’s death. 60 Mr. McGuire explained that his brother-inlaw, Jerry Richardson, forced Joy to have sex with him and that he “[s]tabbed her ‘in
the shoulder bone’ and ‘cut her throat’.” 61 The autopsy report revealed that Joy had
been stabbed twice and the coroner had found an abundant amount of sperm. 62
However, while in prison, Mr. McGuire spoke to different people about Joy’s murder,
implicating himself by stating he was going to blame it all on his brother-in-law, Jerry
Richardson.63 After DNA and blood testing of Mr. McGuire, his brother-in-law Jerry
Richardson, and the victim, “McGuire was indicted on one count of aggravated
murder, with one felony-murder specification for rape.”64 Mr. McGuire was also
indicted on two counts of rape (vaginal and anal) and one count of kidnapping. 65 The
indictment included a death penalty specification, which alleged that McGuire was the
principal offender in an aggravated murder, which occurred while he was committing,

See Johnson, supra note 11 (“During his Jan. 16, 2014, execution, McGuire choked and
coughed for about 20 minutes before succumbing to the drug mixture. His son and daughter,
who witnessed the execution, sued the state, alleging his death was cruel and unusual
punishment.”).
54

55

See Capital Crimes Annual Report, supra note 40 at *235.

56

See Johnson, supra note 11.

57

See State v. McGuire, 686 N.E.2d 1112, 1115 (Ohio 1997).

58

Id.

59

Id.

60

Id.

61
Id.; see also id. (After describing in explicit detail how his brother-in-law, Jerry
Richardson, murdered the Ms. Stewart, McGuire led investigators to a hayloft in a barn where
the murder weapon, a knife was stored).
62

Id.

63

Id. at 1116.

64

Id.

65

Id.
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attempting to commit, or fleeing immediately after committing a rape. 66 Mr. McGuire
pleaded not guilty to all counts,67 but the jury returned a verdict of guilty including the
death sentence specification, which the trial judge imposed. 68 The Ohio Court of
Appeals for Preble County affirmed the death sentence of Mr. McGuire. 69
On appeal, the Supreme Court of Ohio affirmed Mr. McGuire’s convictions and
the death sentence.70 The Supreme Court reasoned that McGuire’s statements tended
to show guilt,71 which combined with the DNA evidence, was consistent with
McGuire’s guilt.72 The Supreme Court reasoned that the mitigating factors of his
turbulent childhood, lack of education, mental abuse and marijuana use did not
outweigh the aggravating factors that he was the principal offender who “committed
rape in conjunction with murder.”73
B. A Rocky Road with Lethal Injection
“People who are detained or imprisoned do not cease to be human beings, no
matter how serious the crime of which they have been accused or convicted.” 74 “The
court . . . which dealt with their case decreed that they should be deprived of their
liberty, not that they should forfeit their humanity.” 75 Our society adheres to a series
of procedures to protect the individual—from the time a person is arrested76 through a
person’s last appeal to the high court. 77 The design of our judicial system in
conjunction with the Eighth Amendment prohibition of cruel and unusual
punishment78 illustrates why every person, no matter the crime committed, should be
treated with dignity and entitled to humane treatment. The safeguards should continue
until a person, specifically on death row, takes their last breath. We as a society should
treat all persons on death row with respect—physical and mentally, which includes
the actual execution process. Therefore, before the execution process even begins,
66

State v. McGuire, No. CA95-01-001, 1996 WL 174609, at *1 (Ohio Ct. App. Apr. 15,
1996); see infra text accompanying notes 31.
67

See McGuire, 1996 WL 174609, at *1.

68

See Id.

69

Id.

70

Id. at 1124.

71

Id. at 1118.

72

Id.

73

Id. at 1123.

74

See Andrew Coyle, A Human Rights Approach to Prison Management 31 (2009),
available at http://www.prisonstudies.org/sites/prisonstudies.org/files/resources/
downloads/handbook_2nd_ed_eng_8.pdf.
75

Id.

76

See generally Miranda v. Arizona, 384 U.S. 436 (1966).

77

See The Appeals Process, UNITED STATES COURTS, http://www.uscourts.gov/
FederalCourts/UnderstandingtheFederalCourts/HowCourtsWork/TheAppealsProcess.aspx
(last visited Mar. 15, 2015).
78

See U.S. CONST. amend. VIII.
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Ohio should be very cautious of where the lethal injection drugs are purchased. The
ODRC should only purchase drugs for lethal injection from FDA-regulated
outsourcing facilities to decrease the likelihood of another botched execution.
1. Ohio: One Too Many People Have Suffered as a Result of Ohio’s Lethal Injection
Procedures
Ohio is no stranger to mishaps occurring with its lethal injection procedures.79 In
addition to Dennis McGuire, Ohio has also botched three other executions: Joseph
Clark, Christopher Newton, and Romell Broom.80
The ODRC continues to amend the execution protocol, namely in the drugs
utilized.81
In previous years, the ODRC repeatedly experienced execution
complications by failing to adequately locate a suitable vein to commence the
executions.82 After the execution of Mr. McGuire, it seems as if those troubles have
been swept under the rug by the ODRC. Presently, the main source of controversy
focuses on where the drugs are purchased. After the execution of Mr. McGuire, the
ODRC should note that the seller of these drugs might be the root of the resulting
complications.
Joseph Clark was sentenced to death on November 28, 1984,83 but the 2006
execution was not seamless. The execution team took 22 minutes to find a suitable
vein for the IV-injection of drugs.84 The overall execution took almost 90 minutes to
complete,85 when the average time from injection of drugs until death lingers around
eight minutes.86 Mr. Clark was able to lift himself off the gurney while stating; “it’s
not working,” during the execution. 87 A year later in 2007, the ODRC followed a

79 See
Ohio
Famous
Cases,
DEATH PENALTY INFORMATION CENTER,
http://www.deathpenaltyinfo.org/ohio-1#sent (“Richard Cooey challenged Ohio's lethal
injection protocol, saying that it would cause a severely painful death. The U.S. Court of
Appeals for the Sixth Circuit rejected his claim, and Cooey was executed on October 14,
2008.”).
80 Id. (“Joseph Clark (May 2006), Christopher Newton (May 2007) and Romell Broom
(September 2009)”).
81 See OHIO EXECUTION PROTOCOL, supra note 20 (On June 9, 2015 the ODRC amended the
Execution Protocol to supersede the April 28, 2014 Execution Protocol).
82

See infra text accompanying notes 83-87.

See Capital Crimes, supra note 40 at 81 (“Clark murdered 22-year-old night clerk David
Manning at a service station in Toledo. Clark demanded money and when Mr. Manning
informed Clark that there was no money, Clark shot Mr. Manning once in the chest. After being
arrested for robbing a bank, Clark admitted to the robbery-murder of Mr. Manning.”).
83

84

See Adam Liptak, Trouble Finding Inmate's Vein Slows Lethal Injection in Ohio, N.Y.
TIMES (May 3, 2006), http://www.nytimes.com/2006/05/03/us/03inmate.html?_r=0.
85

Id.

86

See Sergo, supra note 3.

87

See Liptak, supra note 84.
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parallel procedure that caused Christopher Newton to suffer during his execution. 88
Similar to the execution of Mr. Clark, the ODRC had difficulties finding a suitable
vein for Mr. Newton.89 The execution team struggled for over an hour during this
execution.90
Unlike Mr. Clark or Mr. Newton, Romell Broom, is the “country’s only survivor
of a botched lethal injection.”91 Mr. Broom suffered even longer during the execution
process; two hours of pain while the execution team, again, tried to find a suitable
vein.92 Not learning from prior mistakes, the ODRC stuck Mr. Boom 18 times with
needles in fruitless attempt to commence the execution.93 Mr. Broom has appealed his
case, and remains on death row until he is assigned a new execution date. 94
2. Ohio: Recent Issues with Lethal Injection
Previously, Ohio used the drug pentobarbital in a one-drug cocktail to carry out
the death sentence.95 However, in 2013, the supply of pentobarbital began to run dry
and prisons all over the country, including Ohio, were in dire need of drugs to continue
executing inmates on schedule.96 The suppliers, typically European manufacturers,
either stopped producing these drugs or refused to sell these drugs to U.S.

88 See Jim Leckrone, Ohio Executes Man Who Killed Prison Cellmate, REUTERS (May 24,
2007), http://www.reuters.com/article/2007/05/24/us-execution-ohio-idUSN24371351
20070524.
89

Id.

90

Id.

91

See Ohio Supreme Court to Rule on Second Execution of Romell Broom, ASSOCIATED
PRESS (June 3, 2014) http://www.theguardian.com/world/2014/jun/03/ohio-supreme-courtromell-broom-botched-execution.
Id. (“An hour into the execution, the Department of Rehabilitation and Correction
recruited a part-time prison doctor with no experience or training with executions to try – again,
unsuccessfully – to find a vein.”).
92

93 Id. (“Broom has said he was stuck with needles at least 18 times, with pain so intense that
he cried and screamed.”)

Id. (Mr. Broom’s attorneys are prepared to argue on his behalf that attempting to execute
him again would “punish him twice for the same offense.” Id. “The State of Ohio argues that
Broom never underwent the execution process since the procedure was called off before the
drugs could be introduced into his veins.” Id.).
94

95

See State by State Lethal Injection, supra note 10.

96

See Id; see generally Johnson, supra note 12.
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distributors.97 As a result, Ohio turned to compounding pharmacies to obtain drugs. 98
Ohio used a new two-drug cocktail of midazolam and hydromorphone, for the first
time, on Mr. McGuire on January 14, 2014.99 However, after the execution of Mr.
McGuire, the ODRC amended the execution protocol,100 replacing midazolam and
hydromorphone with either pentobarbital or thiopental sodium. 101 In Ohio’s recently
updated execution protocol, the ODRC does not specify where to obtain the lethal
injection drugs, but rather includes a host of potential suppliers including a
manufacturer, distributor or compounding pharmacy. 102 Compounding pharmacies
pose a plethora of dangers because they “do not face the same approval process for
their products that large manufacturers face, leading to concerns about the safety and
efficacy of their products.”103

97 See Johnson, supra note 12; see id. Cf. Denno, supra note 13, at ¶ 28 (“. . . pentobarbital
was manufactured in Denmark by Lundbeck, Inc. Lundbeck announced a prohibition against
use of the drug for executions, and Ohio's supply was subsequently exhausted. As a result, in
October of 2013, Ohio adopted an “alternate” clinically untested drug mixture containing
midazolam and hydromorphone”). See also COUNCIL OF EUROPE PUBL’G & RENATE
WOHLWEND LIECHTENSTEIN DELEGATION TO THE PARLIAMENTARY ASSEMBLY OF THE COUNCIL
OF EUROPE, THE DEATH PENALTY ABOLITION IN EUROPE 55 (1999) (“Europe has become de facto
a death-penalty free zone, with all of the Council of Europe’s forty-one member states either
having abolished the death penalty, or having instituted a moratorium on executions”).
98

See Johnson, supra note 12.

99 See State by State Lethal Injection, supra note 10; see also Ohio Execution Protocol,
supra note 20 (For the execution of Dennis McGuire, in January 2014, Ohio used the
combination of midazolam and hydromorphone: “If a sufficient quantity of pentobarbital is not
available, or if at any time the available pentobarbital is deemed unusable by the Medical Team,
then the scheduled execution shall proceed with intravenous administration of midazolam and
hydromorphone, in accordance with the terms of this policy”).
100 See Ohio Execution Protocol, supra note 20 (Replacing the combination of
hydromorphone and midazolam, Ohio switched, on January 9, 2015, to pentobarbital or sodium
thiopental:

If a sufficient quantity of pentobarbital or thiopental sodium is available, then the
scheduled execution shall proceed with intravenous administration of either
pentobarbital or thiopental sodium, as determined by the Warden, in accordance with
the terms of this policy. If a sufficient quantity of pentobarbital or thiopental sodium is
not available, or if at any time the available pentobarbital or thiopental sodium is
deemed unusable by the Medical Team, then the Warden shall consult with the Director
and they shall notify the Governor.
101

See State by State Lethal Injection, supra note 10.

102 See Ohio Execution Protocol, supra note 20, at 8. (References pentobarbital or thiopental
sodium, however lists suppliers of this drug vary which are still “in accordance with this
policy”).
103 See Compounding Pharmacies and Lethal Injection, DEATH PENALTY INFORMATION
CENTER, http://www.deathpenaltyinfo.org/compounding-pharmacies (last visited August 13,
2015).
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C. Compounding Pharmacies: A Way for Prisons to Bypass Regulation
Compounding pharmacies are different from commercial pharmacies because they
combine, mix, or alter drugs, which are used to meet the specific needs of an individual
patient in response to a prescription.104 Even though a licensed pharmacist prepares
compounded drugs, compounding pharmacies, as a whole, are not governed under the
strict requirements of the Food and Drug Administration (“FDA”).105 This leaves the
requirements and standards of the pharmacists to be regulated by state pharmacy
boards, which vary from state to state. 106 Compounding pharmacies may elect to
become accredited by the Pharmacy Compounding Accreditation Board, however it
is not a mandatory requirement.107
Due to the lack of uniformity among the states to regulate compounding
pharmacies, there was concern that some pharmacies were straying from the scope of
traditional compounding practices.108 The FDA issued two reports revealing
compounded drugs that failed safety and efficacy tests, as well as exposing serious
illnesses and deaths that had occurred in association with compounded drugs. 109 These
reports failed to fix the problems compounding pharmacies posed and as a result in
October 2012, the New England Compounding Center (“NECC”) was the root of a
fungal meningitis outbreak in the United States. 110 The drugs from this compounding
pharmacy harmed over 700 people in 20 states, and left over 60 people dead.111
Congress responded in November 2013 by passing the Drug and Quality Security
Act.112 Encompassed within this Act is the Compounding Quality Act, which makes
“a distinction between traditional compounders who work at the neighborhood
Id. See also Denno, supra note 13, at 1367 (“Traditionally, all compounded drugs were
custom-made in small batches for individual patients pursuant to a medical prescription.
Physicians usually prescribe compounded medications when commercial drugs are unavailable
or the use of existing commercial alternatives is inhibited by allergies”).
104

105

See Denno, supra note 13, at 1367.

Id. at 1367-68. See also State Regulation of Compounding Pharmacies, NAT’L
CONFERENCE OF STATE LEGISLATURES (Oct. 1, 2014), http://www.ncsl.org/research/
health/regulating-compounding-pharmacies.aspx (“Every state has laws and regulations
guiding pharmacy standards and requirements, addressing issues such as required licenses for
each facility and for the credentialed pharmacists and other employees who work there”).
106

107

See Compounding Pharmacies and Lethal Injection, supra note 103.

108

See Denno, supra note 13, at 1370.

109

Id.

110

Id. at 1371.

111

See Compounding Pharmacies and Lethal Injection, supra note 103; see also T.R.
Goldman, Regulating Compounding Pharmacies, HEALTH AFFAIRS (May 1, 2014),
http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=114
(“An
FDA
investigation later revealed that one-quarter of the steroid vials in an NECC bin contained a
greenish black foreign matter. Hit with a raft of lawsuits, NECC declared bankruptcy, and in
late 2013 the company's owners and its insurers reportedly reached an agreement in principle
for a compensation fund of more than $100 million”).
112 See Denno, supra note 13, at 1374; see also Drug Quality and Security Act, 21 U.S.C. §
503(b) (2013).
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pharmacy and companies producing large quantities of compounded drugs without the
need for a prescription.” 113 This Act leaves regulation over traditional small-scale
compounding pharmacies in the hands of the states. 114 On the other hand,
compounding pharmacies that mass-produce drugs may register with the FDA as
outsourcing facilities.115 Under the Compounding Quality Act, outsourcing facilities
are subject to rules on quality control and oversight. 116 The loophole that puts prisons
at an advantage is that large-scale compounding pharmacies are not mandated to
register with the FDA.117 As a result, small-scale compounding pharmacies and largescale compounding pharmacies that opt out of FDA registration provide available
means for prisons to purchase drugs for lethal injections.
There are allegations that Ohio took advantage of this loophole by purchasing
drugs from compounding pharmacies to carry out executions. 118 Moreover, it is
alleged that the ODRC purchased hydromorphone and midazolam from Hospira, Inc.,
a compounding pharmacy and distributor, which was utilized in the botched execution
of Dennis McGuire.119 These matters are still pending in court, however, Ohio’s
execution protocol allows the ODRC to obtain drugs from compounding
pharmacies.120 As a result of the mishap by the ODRC concerning Dennis McGuire,
and “[i]n light of the continuing need for discovery and necessary preparations related
to the adoption and implementation of the new execution protocol,”121 all executions
have been halted in Ohio until January 2016.122
III. ARGUMENT: OHIO SHOULD PURCHASE DRUGS ONLY FROM FDA-REGISTERED
OUTSOURCING FACILITIES
The ODRC is following in the dark footsteps of Oklahoma. Ohio and Oklahoma
have remarkably similar track records regarding lethal injection.123 Both states have
113

See Goldman, supra note 111.

114

See Denno, supra note 13, at 1374.

115 Sabrina Tavernse, Bill on Drug Compounding Clears Congress a Year After a Meningitis
Outbreak, N.Y. TIMES (Nov. 18, 2013), http://www.nytimes.com/2013/11/19/us/bill-onregulating-drug-compounding-clears-senate.html?module=Search&mabReward=relbias
%3Aw.
116

Id.

117 See generally Denno, supra note 13, at 1374 (“The Act refers to these large scale
compounding manufacturers as outsourcing facilities and provides voluntary federal
registration for outsourcing facilities, set to begin in fiscal year 2015”).
118

See In re Dennis R. McGuire, supra note 1, at ¶¶ 82-83.

See id. at ¶ 73. It is also alleged “Hospira products have been used in at least five
executions in the state of Ohio since at least November 2012.” Id. at ¶ 83.
119

120

See Ohio Execution Protocol, supra note 20 at 8.

121

See Execution Schedule, supra note 21.

122

See id. The first scheduled execution is Ronald Phillips on January 21, 2016. Id.

123

See generally Amanda Sakuma, Oklahoma Executes First Inmate Since Botched Lethal
Injection, MSNBC (Jan. 15, 2015), http://www.msnbc.com/msnbc/first-lethal-injectionoklahoma-botched-inmates-execution.
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used a similar combination of drugs that resulted in botched executions. 124 While
Oklahoma hides behind its secrecy statute125 to protect the identities of the suppliers,
Oklahoma has not tried to hide the fact that the Department of Corrections is open to
using compounding pharmacies.126 Keeping in line with Oklahoma’s actions, Ohio,
too, recently enacted a secrecy statute known as House Bill 663 (“HB 663”).127 HB
663 protects the ODRC from what it has already done, provide immunity and
confidentiality to all persons involved in the lethal injection process, including
compounding pharmacies.128

124

See generally Radelet, supra note 18.

125
See 22 Okla. Stat. Ann.tit. 22, § 1015(B) (West, Westlaw current with chapters of the
Second Regular Session of the 54th Legislature (2014) effective September 1, 2014) (“The
identity of all persons who participate in or administer the execution process and persons who
supply the drugs, medical supplies or medical equipment for the execution shall be confidential
and shall not be subject to discovery in any civil or criminal proceedings. The purchase of drugs,
medical supplies or medical equipment necessary to carry out the execution shall not be subject
to the provisions of the Oklahoma Central Purchasing Act”).
126

See Erik Eckholm, One Execution Botched, Oklahoma Delays the Next, N.Y. TIMES (Apr.
29, 2014), http://www.nytimes.com/2014/04/30/us/oklahoma-executions.html?_r=0 (“Faced
with shortages, Oklahoma and other states have turned to compounding pharmacies — lightly
regulated laboratories that mix up drugs to order. Opponents have raised questions about quality
control, especially after the widely reported dying gasps of a convict in Ohio for more than 10
minutes, and an Oklahoma inmate’s utterance, “I feel my whole body burning,” after being
injected with compounded drugs”).
127 See Death Penalty Legislation HB 663 Death Penalty Legislation, ACLU OF OHIO,
http://www.acluohio.org/legislation/2013-2014-hb-663 (last visited Jan. 15, 2015) (“HB 663
excludes from the definition of “public record” any information and records that relate in any
manner to the execution of a death sentence. These records are made confidential, and not
subject to any form of disclosure under the Public Records Law, as well as for the media and
defense counsel during any legal cases. This includes determining the manufacturing origin of
any drugs used during the lethal injection process or the combination of drugs that may be
administered”); see also H.B. 663, 130th Gen. Assemb., Reg. Sess. (Oh. 2014) (“To amend
section 149.43 and to enact sections 2949.221 and 2949.222 of the Revised Code to provide
confidentiality and license protection for persons and entities involved in executing a sentence
of capital punishment by lethal injection and to void as against public policy any agreement that
prevents the supplying of any drug or drugs to be used in executing a sentence of capital
punishment by lethal injection, and to amend the version of section 149.43 of the Revised Code
that is scheduled to take effect on March 20, 2015, to continue the provisions of this act on and
after that date”).

See Strauss, supra note 26; see also Ohio Execution Protocol, supra note 20, at 11 (“If
the Warden determines that a sufficient quantity of pentobarbital is available and has been
selected to be used, then a Drug Administrator shall prepare the execution drugs as follows:”
128

Syringes 1 and 2: Five (5) grams of pentobarbital (under whatever name it may be
available from a manufacturer, distributor or compounding pharmacy), 100 ml of a
50mg/mL solution, shall be withdrawn and divided into two syringes labeled “1” and
“2”.
Syringes 3 and 4: Five (5) additional grams of pentobarbital (under whatever name it
may be available from a manufacturer, distributor or compounding pharmacy), 100 ml
of a 50mg/mL solution, shall be obtained and kept available in the Equipment Room,
but need not be withdrawn into syringes unless the primary dose of five grams proves
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A. Ohio and Oklahoma Have Used the Same Drug That Resulted in Botched
Executions
Ohio has used many different drugs to carry out lethal injections over the past few
years.129 In 2009, Ohio used sodium thiopental, 130 but switched to pentobarbital in
2011.131 After the pentobarbital supply dried up, Ohio turned to a new two-drug
combination of midazolam and hydromorphone. 132 This two-drug combination was
used for the execution of Dennis McGuire. 133 Midazolam is used because it “is an
anesthetic used sometimes in surgery, and hydromorphone is a narcotic pain killer.”134
The midazolam is thought to render the inmate unconscious for the execution . . . and
hydromorphone causes death by shutting down breathing and stopping the heart from
beating.135 In response to Dennis McGuire, beginning in 2015, Ohio’s amended drug
cocktail for lethal injection includes either pentobarbital, or a dose of thiopental
sodium.136
After the botched execution of Dennis McGuire, the administrators of his estate
filed a complaint as a result of the misguided decisions of the ODRC. 137 The
complaint alleges that the ODRC adopted this compounded two-drug protocol without
any prior clinical testing.138 Despite medical testimony and warnings, the ODRC went

to be insufficient for the procedure. These two additional syringes labeled “3” and “4”
shall be kept available for contingent use. (emphasis added).
A similar procedure is to be followed if the ODRC uses thiopental sodium. Id.
129 See State by State Lethal Injection, supra note 10 (Ohio used pentobarbital in 2011 and
switched to midazolam and hydromorphone in 2014. Id. Recently, the ODRC announced plans
to utilize sodium thiopental or pentobarbital. Id.).
130 See Julie Carr Symth and Andrew Welsh-Huggins, Ohio Clears Specialty Drug-Makers
in Executions, ASSOCIATED PRESS (Oct. 4, 2013), http://bigstory.ap.org/article/ohio-announcesalternative-lethal-injection-drug.
131

Id.

132

Compare State by State Lethal Injection, supra note 10, with In re Dennis R. McGuire,
supra note 1, at ¶ 28 (“As described in greater detail herein, pentobarbital was manufactured in
Denmark by Lundbeck, Inc. Lundbeck announced a prohibition against use of the drug for
executions, and Ohio's supply was subsequently exhausted. As a result, in October of 2013,
Ohio adopted an “alternate” clinically untested drug mixture containing midazolam and
hydromorphone”).
133

Id.

134

Ben Brumfield, Arizona Execution Raises Questions Over Novel Lethal Injections, CNN
(July 25, 2014), http://www.cnn.com/2014/07/24/justice/lethal-injection-controversy/.
135

Id.

136

See Andrew Welsh-Huggins, Ohio Drops 2-Drug Lethal Injection Method, Delays
Execution, ABCNEWS (Jan. 8, 2015), http://abcnews.go.com/US/wireStory/apnewsbreak-ohioexecution-drug-supply-expires-april-28082090.
137

See generally In re Dennis R. McGuire, supra note 1.

See id. at ¶ 39. (Prior to the execution, Dr. David Waisel “testified that midazolam can
induce sedation, however a person can still consciously experience one's surroundings and feel
pain and horrific stimuli, including air hunger, while under sedation.” Id. at ¶ 52. Furthermore,
138
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forward with the two-drug plan of hydromorphone and midazolam, which caused Mr.
McGuire to experience intolerable pain and suffering. 139
Similarly enough, Oklahoma used midazolam as part of a three-drug combination
in the botched execution for Clayton Lockett.140 After challenging Oklahoma’s secrecy
statute, the Oklahoma Supreme Court denied to stay the execution of Clayton
Lockett.141
Oklahoma then proceeded to use “midazolam, which causes
unconsciousness; vecuronium bromide, which stops respiration; and potassium
chloride, which stops the heart.”142 Similar to Ohio, which used an untested
combination that included midazolam, the first time Oklahoma used midazolam was
for the execution of Clayton Lockett. 143 As a result, according to the Oklahoma
Department of Corrections, Clayton Lockett later suffered a heart attack and died. 144
Midazolam contributed to both botched executions, as it was an ingredient in both
drug cocktails for Mr. McGuire and Mr. Lockett.
B. Compounding Pharmacies and Secrecy Statutes Do Not Provide Any Solutions
Compounding pharmacies provide a convenient pathway for prisons to obtain
drugs for lethal injections. Ohio’s death sentence statute145 provides no guidance on
where to purchase these drug cocktails, but the recently updated146 execution protocol
explicitly permits the ODRC to utilize compounding pharmacies. 147 The protocol
specifically designates the Warden to be in charge “and responsible for carrying out
Dr. Waisel testified, “hydromorphone is not generally administered to induce amnesia.” Id. at ¶
54).
See id. at ¶ 63 (“Decedent repeated cycles of snorting, gurgling and arching his back,
appearing to writhe in pain. It looked and sounded as though he was suffocating. His stomach
was rising and falling quickly, as he took quick, shallow breaths. This continued for nearly 19
minutes. The noises he made were audible the entire time, though they gradually quieted as he
was dying. Decedent was conscious during the majority of this time”).
139

140 See Matt Pearce, Molly Hennessey-Fiske, Paresh Dave, Oklahoma Halts Double
Execution After One is Botched, L.A. TIMES (Apr. 29, 2014), http://www.
latimes.com/nation/nationnow/la-na-nn-oklahoma-execution-20140429-story.html#page=1.
141

Lockett v. Evans, 330 P.3d 488, 491 (Okla. 2014)

142

See Pearce, supra note 140.

143

OKLA. DEP'T. OF PUB. SAFETY, THE EXECUTION OF CLAYTON D. LOCKETT, available at
http://www.dps.state.ok.us/Investigation/14-0189SI%20Summary.pdf (“The new three drug
protocol utilized in this execution included the administration of midazolam, vecuronium
bromide and potassium chloride. It was determined vecuronium bromide and potassium
chloride had both been used in previous executions as the second and third drugs to be
administered. This was the first Oklahoma execution where midazolam was used. On April
14, midazolam was the newest drug added to the protocol after it was determined
pentobarbital was not available”) (emphasis added).
144

See Pearce, supra note 140.

145

See Ohio Rev. Code Ann. § 2949.22 (West 2015)

See Ohio Execution Protocol, supra note 20, at 1 (Ohio’s protocol was updated April 14,
2014 and again on January 9, 2015).
146

147

See id. at 8.
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the death sentence on the date established by the Ohio Supreme Court.”148 Absent any
statutory requirements, the execution protocol places the power in the Warden’s hands
to determine what drugs to utilize, how much of each quantity shall be ordered and
most important, where to purchase these drugs. 149 In promulgating this new protocol,
the ODRC included a host of potential suppliers, which gives a false appearance, to
the public, of using a reputable and safe supplier. The protocol allows the Warden to
“order execution drugs from a licensed pharmacist at the Central Pharmacy at the
Department on Mental Health,150 or any other licensed pharmacist.” 151 However, a
few pages later in the protocol, the ODRC expands the potential supplier list to include
any manufacturer, distributor or compounding pharmacy. 152 Ohio’s execution
protocol does not address the real issue of the dangers posed by compounding
pharmacies and includes all possible suppliers to maintain flexibility in times of
disarray. The newly updated execution protocol is expansive in providing options for
the ODRC, but leaves prisoners with limited options. Based on Ohio’s newly enacted
secrecy statute, the enormous power of the Warden, and lack of adequate protections
in the execution protocol, death row inmates can be subject to untested drugs from an
unregulated compounding pharmacy.
1. Ohio
The administrators of Mr. McGuire’s estate named the ODRC’s Warden, Donald
Morgan,153 as one of many defendants in the complaint filed on his behalf. The
complaint alleges that the Warden purchased hydromorphone and midazolam from
Hospira, a compounding pharmacy and distributer.154 The plaintiffs have a good faith
factual basis for this claim because in 2011 Hospira had manufactured and sold sodium

148

Id. at 3.

149

See id. at 5-6.

Compare Ohio’s Pharmacy Service Center, http://mha.ohio.gov/Default.aspx?tabid=370
(“The Ohio Pharmacy Service Center (OPSC) provides pharmaceuticals to governmental and
qualifying entities in Ohio. Over-the-counter drugs, medical and laboratory supplies, personal
care products and forms are also stocked”), with Ohio’s Central Pharmacy Inpatient,
http://mha.ohio.gov/Default.aspx?tabid=367 (“Central Pharmacy Inpatient (CPI) has been
providing comprehensive, centralized pharmaceutical services for more than 30 years. CPI
focuses on best practices for patient care within state, county, or governmental inpatient settings.
CPI offers competitively priced medications through consolidated purchasing, formulary
management, medication monitoring, and coordinated care to ensure that health care dollars are
spent wisely”), and Ohio’s Central Pharmacy Outpatient, http://mha.ohio.gov/Default.
aspx?tabid=368 (“CPO assists Community Mental Health Boards with the economic purchase
and dispensing of psychotropic medications to needy clients meeting specific clinical and
income eligibility criteria”).
150

151

See Ohio Execution Protocol, supra note 20, at 5.

152

See Ohio Execution Protocol, supra note 20, at 8.

See In re Dennis R. McGuire, supra note 1, at ¶ 10 (“Defendant Donald Morgan is the
Warden at Southern Ohio Correctional Facility (“herein SOCF”). He is responsible for
overseeing all operations at SOCF, including executions. He was present during Decedent's
execution. He was acting in his official and individual capacity as such”).
153

154

Id. at ¶¶ 108-109.
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thiopental to the ODRC to use in the executions for that year.155 Because Hospira
previously sold compounded drugs, 156 in conjunction with the present allegations, the
ODRC is adhering to the new execution protocol that allows compounding pharmacies
to provide the Warden’s choice of drugs.
2. Oklahoma
Oklahoma’s execution protocol differs from Ohio’s execution protocol regarding
the suppliers of drugs.157 Oklahoma has passed not only a secrecy statute,158 to protect
the identity of suppliers, but also incorporated the secrecy requirement in their
execution protocol.159 Ohio too, passed a secrecy bill, mainly to shield the identity of
155

See generally Letter from Keês Gioenhout, Vice President, Clinical Research and
Development, Hospira, Inc., to Ohio Department of Rehabilitation and Correction (Mar. 31,
2010 (available at http://www.deathpenaltyinfo.org/documents/HospiraMarch2010Statement.
pdf)
156

See id.

157

Compare Ohio Execution Protocol, supra note 20, at 8 (the ODRC is permitted to obtain
drugs from a manufacturer, compounding pharmacy or distributer), with Oklahoma Execution
Protocol, infra note 159, at 4 (the Oklahoma Department of Corrections is not permitted to
disclose where the execution drugs are purchased, as disclosure is prohibited by their secrecy
statute).
158 See 22 Okla. Stat. Ann. tit. 22, § 1015 (Westlaw 2014) (“The identity of all persons who
participate in or administer the execution process and persons who supply the drugs, medical
supplies or medical equipment for the execution shall be confidential and shall not be subject
to discovery in any civil or criminal proceedings. The purchase of drugs, medical supplies or
medical equipment necessary to carry out the execution shall not be subject to the provisions of
the Oklahoma Central Purchasing Act”); see also Adam Lozeau, Obscuring the Machinery of
Death: Assessing the Constitutionality of Georgia’s Lethal Injection Secrecy Law, 32 LAW &
INEQ. 451, 467 (2014) (Oklahoma is not the only state with a secrecy statute and “in early 2013,
Arkansas, South Dakota, and Tennessee amended their states' public records laws to shield the
identities of the suppliers of lethal injection drugs from disclosure under their public records
acts.”) Id. “A law enacted in March 2013 in Georgia went even further.” Id. “The law, known
as the “Lethal Injection Secrecy Act,” states:

The identifying information of any person or entity who participates in or administers
the execution of a death sentence and the identifying information of any person or entity
that manufactures, supplies, compounds, or prescribes the drugs, medical supplies, or
medical equipment utilized in the execution of a death sentence shall be confidential
and shall not be subject to disclosure under Article 4 of Chapter 18 of Title 50 or under
judicial process. Such information shall be classified as a confidential state secret. Id.
After Georgia’s secrecy statute was passed, an inmate filed for a stay of execution.
See id. at 468. “The presiding judge delayed the execution, and just three days later,
found the law unconstitutional under the Eighth Amendment of the federal
Constitution and under the Separation of Powers Clause of the Georgia State
Constitution.” Id. “The stay of execution is in effect until the Georgia Supreme Court
rules on the constitutionality of the law.” Id.
159

See Oklahoma Execution Protocol, OKLAHOMA DEPARTMENT OF CORRECTIONS, http://
www.ok.gov/doc/documents/op040301.pdf (last updated Sept. 30, 2014) (“Maintaining
confidentiality of identifying information regarding any person who participates in or performs
any function of an execution. As defined in Oklahoma State Statute Title 22, Section 1015, “The
identity of all persons who participate in or administer the execution process and persons who
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the suppliers,160 but did not include the secrecy component in the updated execution
protocol that took effect on January 9, 2015. The Oklahoma Supreme Court held the
secrecy statute constitutional,161 which poses a significant problem as it shields the
company responsible for providing the drugs used in botched executions. The media
has alleged that Oklahoma resorted to compounding pharmacies as a result of drug
shortages.162 Despite these allegations, people not directly involved in executions will
never truthfully know where the Oklahoma Department of Corrections obtains drugs.
3. Secrecy Statutes Provide No Cure to Botched Executions
Ohio is similar to Oklahoma in that both Departments of Corrections seem to have
a false sense of security. For Oklahoma, the secrecy statute did not provide a solution
to the botched execution of Clayton Lockett. Looking at Oklahoma, Ohio should note
that the neither a secrecy statute nor including a vague host of suppliers solves the
problems that resulted from the botched execution of Dennis McGuire, or provides a
solution for upcoming executions. Both states have the appearance of hiding behind
a cloak of invisibility163 instead of addressing the root of the problem—where these
drugs are purchased. Instead of covering up the identities of suppliers, 164 Ohio should
be forthcoming on where they obtain drugs for lethal injection for the bodily health
and respect of the inmate. The ODRC seems to be covering their tracks leading up to
the executions, knowing that the statute will protect and cover up suspicious behavior
by persons involved with lethal injection. Ohio’s enactment of HB 663 was
conveniently passed after Oklahoma’s mishaps with Clayton Lockett, the enactment
of Oklahoma’s secrecy bill and the ODRC’s botched execution of Dennis McGuire.
In reality, Ohio’s enactment of HB 663 is a band-aid on open wound that needs stitches
to heal properly.
Ohio should exclude the use of small-scale state regulated compounding
pharmacies and large-scale compounders that do not elect to register with the FDA as
an outsourcing facility. Ohio should only purchase drugs for lethal injections from an
FDA-registered outsourcing facility. Ohio would be taking a small, albeit proactive
step, to ensure that the drugs are coming from a pharmacy with FDA oversight.

supply the drugs, medical supplies or medical equipment for the execution shall be confidential
and shall not be subject to discovery in any civil or criminal proceedings. The purchase of drugs,
medical supplies or medical equipment necessary to carry out the execution shall not be subject
to the provision of the Oklahoma Central Purchasing Act”).
160

See Death Penalty Legislation, supra note127.

161 See Lockett v. Evans, 330 P.3d 488, 491 (Okla. 2014) (holding that the “secrecy provision
of death sentence statute did not violate inmates' constitutional right of access to the courts”).

See Eckholm, supra note 126 (“Faced with shortages, Oklahoma and other states have
turned to compounding pharmacies — lightly regulated laboratories that mix up drugs to
order”).
162

163 See generally Louis E. Wolcher, Keynote Address, 17 J. L. BUS. & ETH. 9, 13 (2011)
(Referencing Plato and the “ancient fable of the Ring of Gyes. This magical ring allowed its
wearer to become invisible at will, and I wonder, as Plato did more than two millennia ago,
whether someone who could put it on would behave the same way if she knew that she never
had to fear the personal consequences of her actions”); see also Plato, REPUBLIC: BOOK II.
164

See Death Penalty Legislation, supra note 127.
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C. Solutions
1. Outsourcing Facilities Versus State-Regulated Compounding Pharmacies
a. Outsourcing Facilities: More Regulations Required by the FDA
Purchasing drugs from outsourcing facilities would assist the ODRC in narrowing
down the current supplier list in the execution protocol to a more reliable provider.
Compounding pharmacies that elect to register with the FDA as an outsourcing
facility165 must comply with CGMP166 [current good manufacturing practices]
requirements, be inspected by FDA, report adverse events and, provide the FDA with
certain information about the products they compound.167
The FDA promulgated a guide to illustrate the their position on current good
manufacturing practices168 pertaining to Compounding Quality Act, specifically
section 503(B) within the Food, Drug and Cosmetic Act.169 This draft contains
detailed explanations regarding: “facilities designs, procedures for maintaining
suitable facilities, environmental and personnel monitoring, equipment and container

165 See Information Concerning Outsourcing Facilities Registration, U.S. FOOD AND DRUG
ADMINISTRATION,
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompoundi
ng/ucm389118.htm (last updated Mar. 14, 2014) (for more information on how to register as an
outsourcing facility see submission #1); see also

Registration for Human Drug Compounding Facilities Under Section 503B of the Federal
Food, Drug and Cosmetic Act, Draft Guidance, U.S. FOOD AND DRUG ADMINISTRATION (Dec.
2013), http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guid
ances/ucm377051.pdf.
166

Drug Applications and Current Good Manufacturing Practice (CGMP) Regulations,
U.S. FOOD AND DRUG ADMINISTRATION, http://www.fda.gov/Drugs/DevelopmentApproval
Process/Manufacturing/ucm090016.htm (last updated Sept. 12, 2014) (“FDA ensures the
quality of drug products by carefully monitoring drug manufacturers' compliance with its
Current Good Manufacturing Practice (CGMP) regulations. The CGMP regulations for drugs
contain minimum requirements for the methods, facilities, and controls used in manufacturing,
processing, and packing of a drug product. The regulations make sure that a product is safe
for use, and that it has the ingredients and strength it claims to have”).
Protecting the Public Health: Examining FDA’s Initiatives and Priorities: Before the S.
Comm. on Health, Education, Labor and Pensions, 113th Cong. 22 (2014) (statement of
Margaret A. Hamburg, M.D., Comm’r of Food and Drugs, Food and Drug Administration),
available at http://www.hsdl.org/?view&did=754891.
167

168

See Guidance for Industry Current Good Manufacturing Practice—Interim Guidance for
Human Drug Compounding Outsourcing Facilities under Section 503B of the FD&C Act, Draft
Guidance, U.S. DEP’T OF HEALTH AND HUMAN SERVICES, U.S. FOOD AND DRUG
ADMINISTRATION, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) (July 2014), http://
www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UC
M403496.pdf.
Id. at 1 (“This interim guidance describes FDA’s expectations regarding compliance with
current good manufacturing practice (CGMP) requirements for facilities that compound human
drugs and register with FDA as outsourcing facilities under section 503B of the Federal Food,
Drug, and Cosmetic Act (FD&C Act)”).
169

116

JOURNAL OF LAW AND HEALTH

[Vol. 29:248

guidelines, production, testing, and packaging and quality assurance.” 170 This guide
includes a section that is likely related to the New England Compounding Pharmacy
fiasco,171 which reads: “[c]ertain elements of facility design are considered critical to
ensuring the quality of compounded sterile drug products.” 172 “For example, all
processing and controlled areas must be clean and free of visible signs of filth, dirt,
mold or mildew, insects, and inappropriate items or debris.”173
Furthermore, outsourcing facilities must comply with written procedures for
production and process controls to ensure that the consistent production of a drug
meets the applicable standards of identity, strength, quality, and purity. 174 One benefit
of electing to use outsourcing facilities is that the FDA requires testing before a
compounded drug is released for distribution.175 Prior testing will assist the ODRC
because outsourcing facilities are required to warrant that the finished product contains
the proper identity and strength of the active ingredient. 176 Moreover, by purchasing
drugs from outsourcing facilities, the ODRC will know that the drugs comply with
proper packaging requirements,177 be of proper quality, and remain sterile through the
labeled expiration date.178 These regulations allow the ODRC to know that the drugs
will produce the intended effects and work properly up until expiration.
Most notable are the strict regulations regarding the equipment utilized in the
compounding process, as well as actual testing before the drug is distributed. 179 Before
a product can even hit the marketplace, outsourcing facilities must have scientifically
proven data to support their reasons for using certain containers or enclosures for the
compounded drugs.180 After selecting appropriate containers or enclosures, these
products must be tested to determine whether they can “maintain the quality of the
finished drug product and sterility over the expiry period.” 181
170

See Guidance for Industry Current Good Manufacturing Practice, supra note 168 (see
table of contents).
171

See text accompanying notes 110-111.

172

See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 3.

173

See id.

174

Id. at 11; see generally 21 C.F.R. § 211.100 (West 2014).

175

See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 14;
see also 21 C.F.R. § 211.165 (West, Westlaw current through Oct. 30, 2014), see also 21 C.F.R.
§ 211.167 (West 2014).
176 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 14;
see also 21 C.F.R. § 211.160(b) (West 2014).
177

See Guidance for Industy Current Good Manufacturing Practice, supra note 168, at 19;
see also 21 C.F.R. § 211.122 (West 2014).
178 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 18;
see also 21 C.F.R. § 211.166 (West 2014).
179 See Guidance for Industry Current Good Manufacturing Practice, supra note 144, at 7;
see also 21 C.F.R § 211.160(b) (West, Westlaw current through Feb. 5, 2015); 21 C.F.R. §
211.84(d)(3) (West, Westlaw current through Feb. 5, 2015); 21 C.F.R. § 211.184 (West 2015).
180

Id.

181

Id.
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After selecting containers, outsourcing facilities must engage in pre-releasing
testing.182 Facilities must compare the projected output and the actual output of the
drug to fix any inconsistencies.183 Any differences between the projected and actual
outcome of compounded drugs are considered indicators of potential problems with
production and must further be investigated and re-tested.184 The mandate of prerelease testing guarantees drugs meet the “final product specifications before their
release for distribution.”185 Outsourcing facilities are required to establish quality
control units which are responsible for ensuring that the finished drug product is not
released until this testing is conducted and the results confirm that the finished drug
product meets certain specifications.186 As an added layer of protection, drugs that are
stored for long periods must be retested to verify the proper identity, strength, quality,
and purity, or after any exposure to natural elements such as air or heat. 187 Pre-release
testing will benefit prisons because the compounded drugs will not only be sterile, but
will have also gone through prior testing such that the drugs will produce the intended
results. By leaving the testing requirements to the outsourcing facility, prisons will
not have to experiment with these drugs on inmates in carrying out a death sentence.
All of the requirements imposed on outsourcing facilities act as additional
precautionary measures, which will curb the likelihood of another botched execution.
When a compounding pharmacy registers as an outsourcing facility the company
is taking a proactive step that illustrates transparency regarding the compounding
processes. “Once an outsourcing facility is registered, the FDA will inspect it within
two months of registration.”188 After the initial inspection, subsequent inspections will
be based on multiple factors including:
the compliance history of the outsourcing facility; the record, history, and
nature of recalls linked to the outsourcing facility; the inherent risk of the
drugs compounded at the outsourcing facility; the inspection frequency and
history of the outsourcing facility, including whether the outsourcing
facility has been inspected within the last 4 years; and whether the
outsourcing facility has registered as an entity that intends to compound
drugs in shortage.189

182 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 14;
see also 21 C.F.R. § 211.165 (West 2014 ); see also 21 C.F.R. § 211.167 (West 2014).
183

Id. at 11.

184

Id.

185

Id. at 14.

186

Id.; see also 21 C.F.R. § 211.22 (West 2014).

187

Id. at 10.

188

See Information Concerning Outsourcing Facilities Registration, supra note 165.

189 See Information Concerning Outsourcing Facilities Registration, supra note 165 (“It is
important to note that “registration means only that FDA has received the information required
to register the facility. It does not mean that the facility is making FDA-approved drugs and it
does not mean it is in compliance with current good manufacturing practice requirements…”)
(emphasis added).
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There are some drawbacks when a pharmacy registers as an outsourcing facility.
Most importantly, drugs compounded at an outsourcing facility are not FDA
approved;190 however purchasers, such as the ODRC, will know that the facility is
complying with good manufacturing practices.191 Additionally, when a pharmacy
registers as an outsourcing facility, an annual establishment fee will be imposed upon
the company.192
There are drawbacks associated when registering as an outsourcing facility, but the
benefits of subjecting the compounding process to FDA oversight provide a better
safeguard for prisons. By choosing to comply with FDA regulations, “compounders
will have an incentive to register as outsourcing facilities in order to enjoy a market
advance, because their products may be perceived to be safer than those produced by
other compounders.”193 Even more beneficial is that the ODRC has several options
for choosing an outsourcing facility because as of February 28, 2014, 30 companies
had registered as outsourcing facilities.194 One outsourcing facility is located in
Poland, Ohio,195 which is approximately five hours196 from Lucasville, Ohio, where
inmates are executed at the Southern Ohio Correctional Facility. 197
b. Small-Scale State Regulated Compounding Pharmacies Are Inadequate
Unlike outsourcing facilities, small-scale compounding pharmacies are regulated
by state pharmacy boards.198 State pharmacy boards can be as large as 20 members,
See id. (“Drugs made by compounders, including those made at human drug
compounding outsourcing facilities, are NOT FDA-approved. This means that they have not
undergone the same premarket review as approved drugs. They lack an FDA review of safety
and efficacy and of manufacturing quality”).
190

See id. (“Although the drugs will not be FDA approved, purchasers of drugs compounded
at a registered outsourcing facility that has had a recent satisfactory FDA inspection will have
some assurance that the conditions at that facility met applicable current good manufacturing
practice standards at the time of the inspection, and the compounded drugs are labeled with the
required information”).
191

192 See Drug Quality and Security Act Boost Regulation of Compounders, Clarifies FDA
Oversight Authority, FDA Enforcement Manual Newsletter (Food and Drug Administration),
Jan. 2014, at 2 (“In addition, outsourcing facilities will be subject to an annual establishment
fee of $15,000, adjusted for inflation. A reduced fee for small businesses -- one-third of the full
fee amount -- will apply to compounders with annual gross sales of $1 million or less. A fee in
the same amount will be charged for each re-inspection of an outsourcing facility”).
193 Id. (“In addition, outsourcing facilities -- unlike other compounders -- will be able to
compound a drug without having a patient-specific prescription”).

See Fed. Drug Adm’r., Registered Outsourcing Facilities, U.S. FOOD AND DRUG
ADMINISTRATION, (Aug. 7, 2015) http://www.fda.gov/Drugs/GuidanceComplianceRegulatory
Information/PharmacyCompounding/ucm378645.htm.
194

195

See id.

196 See MapQuest directions from Lucasville, Ohio to Poland, Ohio, http://www.mapquest.
com/#f9c3783bd47f9f6509621695.
197

See Capital Punishment in Ohio, supra note 27 (“The "Death House" remains at the
Southern Ohio Correctional Facility”).
198

See Denno, supra note 13, at 1367-68.
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or as small as five members, all who are appointed by the Governor. 199 State
pharmacy boards are responsible for all pharmacy practices that occur in the state. 200
Inspections of pharmacies occur in different fashions: a scheduled in-person
inspection, a surprise inspection, or a self-inspection.201 Self-inspections are
troublesome because pharmacies submit responses to questionnaires essentially
declaring the pharmacy is in compliance with state law. 202 Self-inspections may lead
pharmacies to exceed the scope of traditional pharmaceutical practices, without any
oversight or punishment from a state pharmacy board.
A congressional report highlighted the states overall inabilities to regulate
compounding pharmacies.203 State pharmacy boards have trouble overseeing
pharmacies physically located in the state and therefore can not oversee compounding
pharmacies in other states who sell and ship compounded drugs across state lines. 204
Further complicating the regulatory scheme is the focus of enforcement efforts. State
pharmacy boards focus their efforts on licensing issues, billing violations, failing to
register with the state, failing to have a licensed pharmacist on site, and violations
related to the use and distribution of drugs.205 Pharmacy boards do not place enough
attention on the safety or scope of compounding practices. 206
The role state pharmacy boards play in the enforcement of pharmaceutical
practices appears to be very low. This congressional report found that states do not
have the proper resources, as evidenced by finding number one:
state boards of pharmacy generally do not know which pharmacies engage
in compounding, do not know whether pharmacies ship compounded drugs
across state lines, and do not know which pharmacies manufacture large
quantities of compounded drugs. In many cases, states are incapable of
even providing accurate information regarding the numbers of registered
pharmacies in their states.207
It is easy to see why many state pharmacy boards do not play an active role in the
oversight of compounding pharmacies—a majority of states do not even require a
compounding license or permit.208 Even more troublesome is that only 13 state
See Edward J. Markey et al., State of Disarray, How State’s Inability to Oversee
Compounding Pharmacies Puts Public Health at Risk, Homeland Security Digital Library (Apr.
15, 2013), http://www.hsdl.org/?%20view&did=735130 (Written by Congressman Ed Markey
(D-MA), Henry Waxman (D-CA), John Dingell (D-MI), Frank Pallone (D-NJ) and Diana
Degette (D-CO)) at 10.
199

200

See id at 2.

201

Id. at 10.

202

See id.

203

See id.

204

Id. at 12.

205

Id. at 12-13.

206

Id. at 13.

207

Id. at 15.

208 Id. (Mississippi and Missouri are the only states that require a specific permit or license
to track certain compounding practices. Id.)
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pharmacy boards know which pharmacies are compounding sterile drugs, and Ohio’s
pharmacy board is not included.209
Another drawback of state regulation is the lack of records kept during inspections.
Without records, states cannot evaluate which pharmacies perform reputable and
lawful compounding practices, or pharmaceutical practices in general. In fact, over
20 states do not keep any type of historical records of inspection, nor track problems
related to compounding.210 This means that states have limited knowledge of issues
regarding contamination, cleanliness, drug potency, drug safety and bulk
manufacturing, just to name a few. 211 Even with a lack of inspection records, states
have reported over 2,000 disciplinary actions instituted against compounding
pharmacies. Disciplinary actions have stemmed from:
issues of unsafe storage, compounding copies of commercially available
drugs, compounding without a prescription, issues with potency, problems
with sterility, use of improper ingredients, and manufacturing large
quantities of drugs outside the scope of a pharmacy license. 212
As most states do not keep any type of inspection records, one can expect that most
states do not memorialize the disciplinary process with great detail.213 Therefore, the
public is left in the dark as to what pharmaceutical practices were violated, and what,
if any, disciplinary actions were taken against a compounding pharmacy. 214 Even
though a few states publish enforcement actions taken against compounding
pharmacies on state websites, the public is still left in the dark. 215 Most websites do
not provide enough information for the public to understand the nature of the violation,
making it virtually impossible to know what prior compounding issues a facility
underwent.216 The lack of adequate record keeping highlights the ineffectiveness of
state pharmacy boards to regulate compounding pharmacies.
State pharmacy boards are also faced with financial restraints and lack of
manpower.217 Generally, state pharmacy boards are composed of few representatives
who must operate with a very limited budget allocated by the state. 218 Because budgets
vary from state to state, compounding pharmacies in different states must succumb to
209 Id. at 17; see also id. at 14. (Only thirteen state boards of pharmacy know which
pharmacies are providing sterile compounding services and only five of these states have
inspectors that are trained to identify problems with sterile compounding. The thirteen state
pharmacy boards include: Alabama, California, Connecticut, Delaware, Iowa, Idaho,
Massachusetts, New Jersey, New York, Oklahoma, Texas, Virginia and Washington).
210

Id. at 20.

211

See id.

212

Id. at 20.

213

Id.

214

Id.

215

Id.

216

Id.

217

Id. at 25.

218

Id.
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varying standards and frequencies of inspections.219 For example, “Nevada currently
has a pharmacy board operating budget that provides for approximately $3,260 per
pharmacy, for which the board is responsible for inspecting, while Indiana’s board of
pharmacy has an operating budget that provides for approximately $173 per
pharmacy.”220 The lack of financial resources poses the question of whether state
pharmacy boards can provide adequate oversight of the compounding process to
ensure the safety of the drugs and protect the public health in general.221 Limited
monetary resources go hand in hand with fewer inspectors employed by state
pharmacy boards. For example, Ohio employs 22 inspectors, which is a significant
number compared to its counterpart states, Vermont, Hawaii and Wyoming, all of
which employ fewer than two pharmacy inspectors. 222 Even if state pharmacy boards
desired to provide and keep adequate inspection and disciplinary records, it would be
virtually impossible due to insufficient capital.
These findings provide only a slight glimpse into the inadequacy of state pharmacy
boards to safely and properly regulate compounding pharmacies. The FDA mandates
more requirements for outsourcing facilities, which assure prisons that the
compounded drugs are suitable for the intended uses.
2. Compounding Pharmacies Have Been Linked to Pain and Suffering
a. Ohio
At 10:31 a.m. after the first syringe was injected223 into Dennis McGuire, he took
a deep breath and clenched his hands into fists.224 “He then made a very loud snorting
sound which could be heard in the witness room without any sound amplification.” 225
Mr. McGuire then proceeded to “make extremely loud noises like he was grunting and
fighting for air at the very same time.” 226 This was one of Ohio’s longest executions
since Ohio reinstated capital punishment in 1999.227
Among the many allegations against the Warden and the ODRC, the family of
Dennis McGuire believes that the execution caused Mr. McGuire to suffer serious
physical harm, serious psychological harm and a lingering, undignified death in which
he endured needless pain and suffering during his execution. 228 Purchasing drugs from
compounding pharmacies attributed to the pain and suffering that ultimately led to the
botched execution of Dennis McGuire. Furthermore, utilizing compounding
219

Id.

220

Id.

221

Id.

222

Id. at 26.

223

See In re Dennis R. McGuire, supra note 1, at ¶ 56.

224

Id. at ¶ 59.

225

Id.

226

Id. at ¶ 61.

227

See Gary Strauss, Ohio Killer's Slow Execution Raises Controversy, USA TODAY (Jan.
16, 2014), http://www.usatoday.com/story/news/nation/2014/01/16/ohio-killer-executed-withnew-lethal-drug-combo/4512651/.
228

See In re Dennis R. McGuire, supra note 1, at ¶ 100.
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pharmacies is in direction contradiction with the Ohio death sentence statute, 229 which
requires “lethal injection to quickly and painlessly cause death.” 230 Further
complicating the execution process is that the terms quick and painless are not defined
statutorily.231 This gives prisons unfettered discretion in determining what constitutes
quick and painless—as the execution is underway. Only after the death of an inmate,
can a court determine whether the execution procedures complied with the ambiguous
statutory requirements—but the damage has already been done. That death row inmate
has already suffered for a period of time based on the standards and procedures
employed by the prison.
b. Oklahoma
Clayton Lockett was executed under Oklahoma’s protocol on April 29, 2014.232
Similar to Dennis McGuire, Mr. Lockett also experienced horrific complications
namely with the IV used.233 Once Mr. Lockett’s execution was stopped, he later died
in the execution chamber.234 As a result, the Governor of Oklahoma ordered an
independent review to look into the procedures employed prior to and during Mr.
Lockett’s execution.235 This report revealed that the IV had been infiltrated that lead
to blood and a clear liquid appearing on Mr. Lockett’s skin. 236 Further, the physician
in the execution chamber noticed significant swelling on Mr. Lockett’s body. 237 As a
result, the execution was halted just as Mr. Lockett was being injected with potassium
chloride.238 The toxicology report indicated that Mr. Lockett’s blood contained a small
amount of the lethal injection drugs. 239 Arguably, the execution was halted for a
variety of reasons including the faulty IV, which was injecting drugs which may have
been purchased from a compounding pharmacy. The Oklahoma protocol and secrecy
229

See Ohio. Rev. Code § 2949.22.

230

Id., see also In re Dennis R. McGuire, supra note 1, at ¶¶ 55, 66 (highlighting the
execution began at 10:27 a.m. and he was pronounced dead at 10:53 a.m., it took over 20
minutes to die); see also Sergo, supra note 3 (“According to a 2002 study in the Journal of
Forensic Science, the average length of time from the first injection to death is 8.4 minutes”).
231

See Ohio. Rev. Code § 2949.22.

See The Execution of Clayton D. Lockett, OKLA. DEP’T OF PUBLIC SAFETY, http://
www.dps.state.ok.us/Investigation/14-0189SI%20Summary.pdf (last visited Nov. 3, 2014).
232

233

Id. at 1.

234

Id.

Id. at 2 (On “April 30, Governor Fallin issued Executive Order 2014-11, which appointed
Secretary of Safety and Security and Department of Public Safety (DPS) Commissioner Michael
Thompson to conduct an independent review of the events leading up to and during Lockett’s
execution”).
235

236

Id. at 18.

237

Id.

238

Id.

Id. at 18 (“On May 14 and May 19, OCME [Oklahoma County Medical Examiner]
documented the toxicology results they received from NMS Labs on an aliquot of the femoral
blood sample they obtained from Lockett’s body on April 30. The results indicated a midazolam
concentration of 0.57 mcg/mL and a vecuronium concentration of 320 ng/mL”).
239

2015] EXPLORING THE FLAWS IN THE OHIO EXECUTION PROTOCOL

123

statute did not provide for a seamless execution, as it was eventually halted in the
middle of the execution.240 Both of the botched executions in Ohio and Oklahoma
illustrate the need to change both execution procedures, which can start with the
pharmacies supplying these drugs.
IV. RECOMMENDATIONS TO THE OHIO DEPARTMENT OF REHABILITATION AND
CORRECTION
Below is a list of recommendations for the Ohio Department of Rehabilitation and
Correction’s current execution protocol pertaining to lethal injection. These
recommendations may assist in curtailing another botched execution and will provide
more transparent information to officials involved in the execution process. The
ODRC should consider the following regarding the current lethal injection protocol:
A. Update the execution protocol sections titled: ‘EXECUTION PREPARATION—
APPROXIMATELY 14 DAYS PRIOR TO THE EXECUTION’241 AND ‘EXECUTION
PREPARATION—APPROXIMATELY 30 DAYS PRIOR TO THE EXECUTION’242 to
explicitly direct the Warden to purchase drugs only from an FDA-registered
outsourcing facility.
B. Update the execution protocol sections titled: EXECUTION PREPARATION—
APPROXIMATELY 14 DAYS PRIOR TO THE EXECUTION’243 AND ‘EXECUTION
PREPARATION—APPROXIMATELY 30 DAYS PRIOR TO THE EXECUTION’244 to
explicitly prohibit the Warden from purchasing drugs from small-scale state
regulated compounding pharmacies and large-scale compounding pharmacies
that do not elect to register with the FDA as an outsourcing facility.
C. Modify the execution protocol section titled: DRUG PREPARATION245 to only
permit the Warden to use drugs from outsourcing facilities and prohibit the
use of drugs purchased from small-scale state regulated compounding
pharmacies and large-scale compounding pharmacies that do not elect to
register with the FDA as an outsourcing facility.
D. Include a list of potential outsourcing facilities in the execution protocol
section titled: DRUG PREPARATION246—to provide another option of
purchasing drugs for lethal injection.
The above-mentioned suggestions are not a complete solution to the various issues
related to the execution process. However, these recommendations may help curtail
the likelihood of another botched execution from occurring in Ohio. Using
outsourcing facilities provides transparency of the drug compounding process, even
in light of Ohio’s recently enacted secrecy statute.247 Purchasing drugs for lethal
injection from an outsourcing facility removes the experimentation factor of whether
240

See id. at 1.

241

Id. at 7.

242

Id. at 5.

243

Id. at 7.

244

Id. at 5.

245

Id. at 11.

246

Id.

247

See generally Death Penalty Legislation, supra note 127.

124

JOURNAL OF LAW AND HEALTH

[Vol. 29:248

the drugs will properly perform because of the strict FDA requirements. The FDA
requirements provide extremely detailed safety, testing and packaging mandates that
ensure compounded drugs will produce the intended effect. 248 Even in light of Ohio’s
recently enacted secrecy statute,249 the ODRC can still adjust the execution protocol
to list outsourcing facilities as a potential provider of lethal injection drugs. 250 If the
general option of purchasing from an outsourcing facility is added to the execution
protocol, the ODRC could still comply with the secrecy statute251 by omitting specific
names of outsourcing facilities. These recommendations will provide more concrete
regulation to the execution protocol and assist in lowering the chances of another
botched execution from occurring.
V. CONCLUSION
The ODRC is not immune to unplanned events occurring during the execution
process. In response to the recent botched execution of Mr. McGuire, and the previous
botched executions of three other inmates, the ODRC should implement several
changes to the current execution protocol. The ODRC continues to amend the drugs
used for lethal injection, when the real source of botched executions may not be the
actual drugs utilized, but may be where the drugs are purchased.
Previously, Ohio turned to compounding pharmacies to purchase these drugs—
facilities that have limited regulation and oversight.252 Compounding pharmacies are
traditionally regulated by state pharmacy boards, which typically cannot provide
enough oversight to regulate the compounding process. 253 However, compounding
pharmacies may elect to register with the FDA as outsourcing facilities.254
Outsourcing facilities are required to follow strict FDA guidelines when compounding
drugs to ensure the drugs produce the intended results. 255 The FDA is better equipped
to regulate the compounding process, as outsourcing facilities must begin the
compounding process by testing containers or enclosures that are appropriate for
certain compounded drugs.256 Furthermore, outsourcing facilities must go through
pre-releasing testing of compounded drugs to ensure the proper identity, strength,
quality, and purity.257 When a compounding pharmacy voluntarily elects to register
as an outsourcing facility, the compounding process must abide by more stringent
safeguards, which in turn assists prisons when purchasing drugs for lethal injection.
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Unlike FDA regulated outsourcing facilities, state pharmacy boards regulate
small-scale compounding pharmacies.258 However, state pharmacy boards do not have
the financial resources or human capital to adequately oversee the compounding
process.259 State pharmacy boards do not focus their efforts to oversee the
compounding process, unlike the FDA. Even more problematic is that most state
pharmacy boards do not keep any type of adequate records pertaining to inspection or
disciplinary actions.260 Without records, the public, people who use drugs purchased
from state regulated compounding pharmacies, including prisons, are unaware of the
compounding practices. Due to the lack of transparency and ineffective management
of state regulation, state pharmacy boards cannot ensure adequate oversight. The FDA
provides more reliable and rigorous requirements for the compounding process and
has the ability to oversee the entire compounding process—down to the very container
used to house the compounded drug.
The main priority for the ODRC should be to change the current practice of
utilizing unregulated and state-regulated compounding pharmacies. Instead, the
ODRC should be more forthcoming when purchasing these drugs to ensure that the
drugs are purchased from a safe supplier with adequate FDA oversight. Ohio should
note that the prior mistakes during executions could have been the result of where the
ODRC obtained these drugs, and not the actual drug utilized. To start, the ODRC
must be more specific in the lethal injection protocol instead of including a long list
of potential suppliers. Ohio has the option to amend the execution protocol to add
outsourcing facilities as a choice for purchasing drugs. Further, the ODRC can choose
to eliminate purchasing drugs from unregulated compounding pharmacies for all
upcoming executions.
Outsourcing facilities abide to more stringent safety requirements that can assist
in preventing another botched execution from occurring. While outsourcing facilities
cannot guarantee a seamless execution, the compounding process is more regulated at
the FDA level, as opposed to its counterpart—state pharmacy boards. The ODRC
should only purchase drugs for lethal injections from compounding pharmacies that
voluntarily choose to register with the FDA as an outsourcing facility.
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